- Report
- November 2023
- 175 Pages
Global
From €4785EUR$5,000USD£4,066GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1914EUR$2,000USD£1,626GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1196EUR$1,250USD£1,016GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1914EUR$2,000USD£1,626GBP
- Report
- May 2024
- 130 Pages
Global
From €6220EUR$6,499USD£5,285GBP
- Report
- May 2024
- 134 Pages
Global
From €6220EUR$6,499USD£5,285GBP
- Report
- March 2024
- 132 Pages
Global
From €5264EUR$5,500USD£4,472GBP
- Report
- March 2024
- 195 Pages
Global
From €3229EUR$3,374USD£2,744GBP
€3588EUR$3,749USD£3,049GBP
- Report
- March 2024
- 194 Pages
Global
From €3229EUR$3,374USD£2,744GBP
€3588EUR$3,749USD£3,049GBP
- Report
- March 2024
- 184 Pages
Global
From €3229EUR$3,374USD£2,744GBP
€3588EUR$3,749USD£3,049GBP
- Report
- March 2024
- 175 Pages
Global
From €4785EUR$5,000USD£4,066GBP
- Report
- January 2024
- 132 Pages
Global
From €7609EUR$7,950USD£6,465GBP
- Report
- April 2024
- 30 Pages
Global
From €2632EUR$2,750USD£2,236GBP
- Report
- October 2023
- 181 Pages
Global
From €4690EUR$4,900USD£3,985GBP
- Report
- May 2024
- 140 Pages
Global
From €6220EUR$6,499USD£5,285GBP
- Report
- May 2024
- 128 Pages
Global
From €6220EUR$6,499USD£5,285GBP
- Report
- November 2023
- 140 Pages
Global
From €2392EUR$2,499USD£2,032GBP
- Report
- June 2023
- 143 Pages
Global
From €2392EUR$2,499USD£2,032GBP
- Report
- February 2024
- 110 Pages
Global
From €4546EUR$4,750USD£3,863GBP
- Report
- December 2023
- 259 Pages
Global
€4781EUR$4,995USD£4,062GBP
The Anti Diarrheal market is a subset of the Gastrointestinal Drugs market, which includes medications used to treat a variety of gastrointestinal disorders. Anti Diarrheal drugs are used to treat diarrhea, which is a common symptom of many gastrointestinal disorders. These drugs work by reducing the amount of water and electrolytes lost in the stool, and by slowing down the movement of the intestines. Commonly used Anti Diarrheal drugs include loperamide, diphenoxylate, and bismuth subsalicylate.
The Anti Diarrheal market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include GlaxoSmithKline, Pfizer, Merck, Johnson & Johnson, and Novartis. Other companies in the market include Sanofi, Bayer, AstraZeneca, and Daiichi Sankyo. Show Less Read more